Eradivir Secures $10 Million in Private Financing to advance its lead antiviral therapeutic, EV25. This financing round supports ongoing development efforts.
Amount Raised
$10 Million
Round Type
Funding Round
Description
Eradivir Inc. has closed a $10 million private financing round to support the development of its lead antiviral therapeutic, EV25, and a second molecule, EV148, for RSV. The funding reflects strong confidence from previous investors. The funds will complete the EV25 Phase 2a study and support IND-enabling studies for EV148
Quick answer
Eradivir raised $10 Million in a Funding Round round, dated October 7, 2025. Eradivir is based in West Lafayette, Indiana, United States.
- How much did Eradivir raise?
- Eradivir raised $10 Million in a Funding Round round on October 7, 2025.
- What does Eradivir do?
- Eradivir is a preclinical biotech company focused on developing antiviral therapeutics.
- Where is Eradivir based and how big is it?
- Eradivir is based in West Lafayette, Indiana, United States. Fundz records about 22 employees.
- Who are the decision-makers at Eradivir?
- Fundz holds 2 contacts at Eradivir. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Eradivir that raised within 45 days of this round, from Fundz verified event records.
- BeyondSpring raised $2M (Funding Round) on November 21, 2025.
- ClearPoint Neuro raised $18M on November 20, 2025.
- BioVaxys Technology Corp. raised $1.5M (Post-IPO Equity) on November 19, 2025.
- VahatiCor raised $23M (Series B) on November 18, 2025.
- FibroBiologics raised $4M on November 18, 2025.
- Bambusa Therapeutics raised an undisclosed amount (Series A) on November 17, 2025.
Who to call at Eradivir, and when
A new round usually means Eradivir is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Eradivir raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Eradivir, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Eradivir. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Eradivir raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Eradivir raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.